DCAF7 and glioblastoma: CPTAC proteomics corroborated the transcript findings that DCAF7 protein was markedly increased in BRCA, COAD, LUAD, pancreatic adenocarcinoma (PAAD) and LIHC, but decreased in UCEC, HNSC and glioblastoma multiforme (GBM) (Figure 1D).